CORTEXYME INC (CRTX) Stock Analyst Ratings
USA - NASDAQ:CRTX - US22053A1079 - Common Stock
1.95 USD
+0.05 (+2.63%)
1.99 USD
+0.04 (+2.05%)
ChartMill assigns a Buy % Consensus number of 45% to CRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.7. This target is 1063.85% above the current price.
CRTX was analyzed by 11 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about CRTX.
In the previous month the buy percentage consensus was at a similar level.
CRTX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-11 | Credit Suisse | Maintains | Underperform |
| 2022-03-09 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-28 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2022-01-27 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2021-10-27 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2021-10-27 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-16 | Canaccord Genuity | Maintains | Buy |
| 2021-08-26 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-17 | Jefferies | Downgrade | Buy -> Hold |
CORTEXYME INC / CRTX FAQ
What is the average price target for CORTEXYME INC (CRTX) stock?
11 analysts have analysed CRTX and the average price target is 22.7 USD. This implies a price increase of 1063.85% is expected in the next year compared to the current price of 1.95.
Can you provide the consensus rating for CORTEXYME INC stock?
The consensus rating for CORTEXYME INC (CRTX) is 45.4545 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed CORTEXYME INC (CRTX)?
The number of analysts covering CORTEXYME INC (CRTX) is 11.